Crees, ZD, Rettig, MP, Jayasinghe, RG, Stockerl-Goldstein, K, Larson, SM, Arpad, I, Milone, GA, Martino, M, Stiff, P, Sborov, D, Pereira, D, Micallef, I, Moreno-Jimenez, G, Mikala, G, Coronel, MLP, Holtick, U, Hiemenz, J, Qazilbash, MH, Hardy, N, Latif, T, Garcia-Cadenas, I, Vainstein-Haras, A, Sorani, E, Gliko-Kabir, I, Goldstein, I, Ickowicz, D, Shemesh-Darvish, L, Kadosh, S, Gao, F, Schroeder, MA, Vij, R, DiPersio, JF. Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial. NATURE MEDICINE. 2023; 29(4)DOI:10.1038/s41591-023-02273-z. PMID:37069359. IF:58.700(Q1/1D).

Perl A.E., Larson R.A., Podoltsev N.A., Strickland S., Wang E.S., Atallah E., Schiller G.J., Martinelli G., Neubauer A., Sierra J., Montesinos P., Recher C., Yoon S.-S., Maeda Y., Hosono N., Onozawa M., Kato T., Kim H.-J., Hasabou N., Nuthethi R., Tiu R., Levis M.J.. Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy. Transplantation And Cellular Therapy. 2023; 29(4)DOI:10.1016/j.jtct.2022.12.006. PMID:36526260. IF:3.600(Q1/3D).

Martin-Fernandez, L, Garcia-Martinez, I, Lopez, S, Martinez-Perez, A, Vilalta, N, Plaza, M, Moret, C, Vinuela, A, Brown, AA, Panousis, NI, Buil, A, Dermitzakis, ET, Corrales, I, Souto, JC, Vidal, F, Soria, JM. Multiallelic Copy Number Variation in ORM1 is Associated with Plasma Cell-Free DNA Levels as an Intermediate Phenotype for Venous Thromboembolism. THROMBOSIS AND HAEMOSTASIS. 2023; 123(04)DOI:10.1055/s-0043-1760844. PMID:36696913. IF:5.000(Q1/2D).

Mussetti, A, Bento, L, Bastos-Oreiro, M, Sansalvador, BR, Albo, C, Bailen, R, Barba, P, Benzaquen, A, Briones, J, Caballero, AC, Campos, A, Espanol, I, Ferra, C, Lopez, SG, Sierra, PAG, Guerra, LM, Hernani, R, Iacoboni, G, Ubieto, AIJ, Kwon, M, Corral, LL, Lopez-Godino, O, Munoz, MCM, Martinez-Cibrian, N, Gomez, JM, Perez-Ortega, L, Ortf, G, Ortiz-Maldonado, V, Pascual, MJ, Perera, M, Perez, A, Reguera, JL, Sanchez, JM, Sanz, J, Torrent, A, Yanez, L, Varela, R, Echechipia, IC, Caballero, D, Sureda, A. Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era. BONE MARROW TRANSPLANTATION. 2023; 58(6)DOI:10.1038/s41409-023-01949-x. PMID:36918682. IF:4.500(Q1/2D).